Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | GPR119 | Q8TDV5 | 15/20 | 0.41 |
| ▸ | ACACB | O00763 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30328105 | 0.85 | CYP11B2 (0.48) | CYP11B2GPR119ACACB | |
| SCHEMBL30328978 | 0.84 | CYP11B2 (0.48) | CYP11B2GPR119ACACB | |
| SCHEMBL30327857 | 0.79 | CYP11B2 (0.48) | CYP11B2GPR119ACACB | |
| SCHEMBL30328552 | 0.79 | CYP11B2 (0.50) | CYP11B2GPR119ACACB | |
| SCHEMBL17925046 | 0.78 | GPR119 (0.54) | CYP11B2GPR119 | |
| SCHEMBL30328924 | 0.78 | CYP11B2 (0.49) | CYP11B2GPR119ACACB | |
| SCHEMBL30328268 | 0.78 | CYP11B2 (0.49) | CYP11B2GPR119ACACB | |
| SCHEMBL30329202 | 0.77 | CYP11B2 (0.48) | CYP11B2GPR119ACACB | |
| SCHEMBL30328302 | 0.77 | CYP11B2 (0.49) | CYP11B2GPR119ACACB | |
| SCHEMBL30328168 | 0.77 | CYP11B2 (0.48) | CYP11B2GPR119ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4415706-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | Vanqua Bio, Inc. (US) | 2024-08-21 | — | — | EP | disclosed |
| WO-2023064343-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | VANQUA BIO, INC. (US) | 2023-04-20 | — | — | WO | disclosed |